📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: NAT Diagnostics

1.1 - Company Overview

NAT Diagnostics Logo

NAT Diagnostics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a molecular diagnostic platform for true point-of-care infectious disease testing in physician offices, clinics, pharmacies, and other sites where patients are seen by medical personnel, delivering highly accurate results to improve the diagnostic experience.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to NAT Diagnostics

Caribou Biosciences Logo

Caribou Biosciences

HQ: United States Website
  • Description: Provider of CRISPR genome-editing technologies and allogeneic CAR-T cell therapies for oncology. Offers chRDNA to enhance precision and reduce off-target effects; off-the-shelf CAR-T therapies for hematologic malignancies and autoimmune diseases; and candidates CB-010 (anti-CD19 for B cell non-Hodgkin lymphoma), CB-011 (anti-BCMA for multiple myeloma), and CB-012 (anti-CLL-1 for acute myeloid leukemia).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caribou Biosciences company profile →
Phthisis Diagnostics Logo

Phthisis Diagnostics

HQ: United States Website
  • Description: Provider of molecular diagnostics products for various infectious diseases, leveraging molecular technology to deliver superior quality, ease of use, and cost savings for laboratories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phthisis Diagnostics company profile →
CustomArray Logo

CustomArray

HQ: United States Website
  • Description: Provider of oligonucleotide pool libraries to many of the world’s premier academic and industrial organizations for applications including synthetic biology, gene synthesis, CRISPR, targeted sequencing, complex DNA libraries, shRNA libraries, and DNA data storage.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CustomArray company profile →
Frugi Bio Logo

Frugi Bio

HQ: United States Website
  • Description: Provider of modular, paper-based, secure diagnostics for viral outbreak management using synthetic biology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Frugi Bio company profile →
Enancio Logo

Enancio

HQ: France Website
  • Description: Provider of high-speed, efficient genomic data compression and decompression, complementing Illumina’s other informatics solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enancio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for NAT Diagnostics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to NAT Diagnostics

2.2 - Growth funds investing in similar companies to NAT Diagnostics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for NAT Diagnostics

4.2 - Public trading comparable groups for NAT Diagnostics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to NAT Diagnostics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About NAT Diagnostics

What does NAT Diagnostics do?

NAT Diagnostics is a provider of a molecular diagnostic platform for true point-of-care infectious disease testing in physician offices, clinics, pharmacies, and other sites where patients are seen by medical personnel, delivering highly accurate results to improve the diagnostic experience.

Who are NAT Diagnostics's competitors?

NAT Diagnostics's competitors and similar companies include Caribou Biosciences, Phthisis Diagnostics, CustomArray, Frugi Bio, and Enancio.

Where is NAT Diagnostics headquartered?

NAT Diagnostics is headquartered in United States.

How many employees does NAT Diagnostics have?

NAT Diagnostics has 1,000 employees 🔒.

When was NAT Diagnostics founded?

NAT Diagnostics was founded in 2010 🔒.

What sector and industry vertical is NAT Diagnostics in?

NAT Diagnostics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for NAT Diagnostics

Who are the top strategic acquirers in NAT Diagnostics's sector and industry

Top strategic M&A buyers and acquirers in NAT Diagnostics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for NAT Diagnostics?

Top strategic M&A buyers groups and sectors for NAT Diagnostics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in NAT Diagnostics's sector and industry vertical

Which are the top PE firms investing in NAT Diagnostics's sector and industry vertical?

Top PE firms investing in NAT Diagnostics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in NAT Diagnostics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in NAT Diagnostics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in NAT Diagnostics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to NAT Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in NAT Diagnostics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for NAT Diagnostics?

The key public trading comparables and valuation benchmarks for NAT Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for NAT Diagnostics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for NAT Diagnostics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in NAT Diagnostics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for NAT Diagnostics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in NAT Diagnostics's' sector and industry vertical?

Access recent funding rounds and capital raises in NAT Diagnostics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for NAT Diagnostics